Chair
Cancer Biology
Cleveland Clinic Lerner Research Institute
United States of America
Yi has been working on tumor immunology and immunotherapy in multiple myeloma (MM) for 20 years. We were first to demonstrate the existence of idiotype-specific T cells in patients with MM and related disorders and that idiotype-specific cytotoxic T cells could lyse autologous primary myeloma cells.
Antitumor immune response; C-reactive protein; Cancer; Drug resistance; Idiotype; Immunotherapy; Mantle cell lymphoma; Monoclonal antibodies; Multiple myeloma; T cells; Tumor microenvironment; Vaccines